Non-small cell lung cancer
Conditions
Interventions
As adjuvant chemotherapy, we do four courses the TS-1 / CBDCA combination therapy: two weeks of rest after two weeks of treatment.
Sponsors
Department of Surgery II, University of Fukui
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The patient was diagnosed with pathologically non-small cell lung cancer, is a pathological stage II / IIIA. 2) The patient has been confirmed pathologically complete resection. 3) In cases of lobectomy or more surgical resection was performed, has also been done lymph node dissection. 4) For non-small cell lung cancer, before treatment (chemotherapy or radiation therapy) other than surgery is not. 5) Performance Status (PS) of ECOG is 0-1. 6) Oral ingestion is possible cases. 7) To have sufficient bone marrow, liver, kidney, and lung function within registration before the 14th. 8) Chemotherapy within 56 days after surgery can begin. 9) Consent document from the patient is obtained.
Exclusion criteria
Exclusion criteria: 1) TS-1 or CBDCA is contraindicated administration. 2) Patients with a history of severe drug hypersensitivity. 3) Patients with obvious interstitial pneumonia or pulmonary fibrosis in the chest X-ray. 4) Patients with metachronous or simultaneity of active multiple cancer. 5) Patients with pleural effusion and ascites and pericardial reservoir requiring drainage. 6) Patients with the following serious complications. 1. Intestinal paralysis, intestinal obstruction 2. Poor control of diabetes or hypertension 3. Cirrhosis, liver failure 4. Renal failure 5. Active infection 6. Heart failure or myocardial infarction within 6 months 7. Other complications, it is determined to cause a serious problem in the treatment enforcement 7) Patients with severe diarrhea. 8) Pregnant women or women that might be pregnant. 9) Other cases attending physician it is determined unsuitable for registration of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Completion rate of treatment | — |
Countries
Japan
Contacts
Public ContactKayo Sakon
University of Fukui Department of Surgery II
Outcome results
None listed